Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FCNAY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,596
Award facts
- Contract value 100% obligated
- $52,596.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $52,596.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. This firm fixed-price delivery order, issued on September 22, 2025, with an ultimate completion date of October 14, 2025, carries no set-aside designation. The order represents a continuation of DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain, leveraging its existing relationship with the Defense Logistics Agency to provide specialized pharmaceutical products to Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency through the SPE2DB program, which is valued at $499,999,999 and extends through November 2026. The underlying indefinite delivery contract provides the framework for the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting military health facilities. The Keytruda delivery fulfills the oncology treatment requirements within this broader pharmaceutical supply agreement.
Quick answers
Who was awarded contract SPE2DB25FCNAY?
SPE2DB25FCNAY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FCNAY worth?
The government has obligated $52,596 on SPE2DB25FCNAY.
Is contract SPE2DB25FCNAY an order under another contract?
Yes. SPE2DB25FCNAY is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCNAY competed?
The extent of competition for SPE2DB25FCNAY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award